Glycoscoredx Limited

DataGardener
live
Micro

Glycoscoredx Limited

12766216•Private Limited With Share Capital

Sandgate House 102 Quayside, Newcastle Upon Tyne, Tyne And Wear, NE13DX

Get Full Access

Visit WebsiteBook a Direct Call
Incorporated

24/07/2020

Company Age

5 years

Directors

4

Employees

3

SIC Code

72110

Risk

not scored

Company Overview

Registration, classification & business activity

Glycoscoredx Limited (12766216) is a private limited with share capital incorporated on 24/07/2020 (5 years old) and registered in tyne and wear, NE13DX. The company operates under SIC code 72110 and is classified as Micro.

Glycoscoredx limited is a diagnostic company developing a new blood test to revolutionise how prostate cancer is diagnosed. built on over a decade of clinical and academic research, the glycoscore prostate cancer test uses a unique combination of biomarkers to provide a clear picture of clinically r...

Private Limited With Share Capital
SIC: 72110
Micro
Incorporated 24/07/2020
NE13DX
3 employees

Financial Overview

Total Assets

£169.3K

Liabilities

£23.4K

Net Assets

£145.9K

Cash

£155.6K

Key Metrics

3

Employees

4

Directors

13

Shareholders

Board of Directors

4
A
allan brown
director
J
jennifer munkley
director
M
matthew leslie pearce
director
M
matthew leslie pearce
director

Filed Documents

33
Gazette Notice Voluntary
Category:Gazette
Date:24-02-2026
Dissolution Application Strike Off Company
Category:Dissolution
Date:17-02-2026
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:23-07-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:17-12-2024
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:29-07-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:20-03-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:06-11-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:26-07-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:26-07-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:26-07-2023
Capital Allotment Shares
Category:Capital
Date:27-06-2023
Capital Name Of Class Of Shares
Category:Capital
Date:15-06-2023
Resolution
Category:Resolution
Date:14-06-2023
Memorandum Articles
Category:Incorporation
Date:14-06-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:05-06-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:20-04-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:16-03-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:16-09-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:25-07-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:05-01-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:18-10-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:29-07-2021
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:29-07-2021
Resolution
Category:Resolution
Date:11-05-2021
Resolution
Category:Resolution
Date:11-05-2021
Memorandum Articles
Category:Incorporation
Date:11-05-2021
Capital Allotment Shares
Category:Capital
Date:27-04-2021
Capital Allotment Shares
Category:Capital
Date:26-04-2021
Memorandum Articles
Category:Incorporation
Date:02-03-2021
Resolution
Category:Resolution
Date:02-03-2021
Capital Allotment Shares
Category:Capital
Date:22-02-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:22-02-2021
Incorporation Company
Category:Incorporation
Date:24-07-2020

Innovate Grants

1

This company received a grant of £209554.0 for Glycoscore: A Reliable Blood Test To Diagnose Prostate Cancer. The project started on 01/04/2021 and ended on 31/08/2022.

Import / Export

Imports
12 Months0
60 Months5
Exports
12 Months0
60 Months0

Risk Assessment

not scored

International Score

Future Factor

excellent

Performance Rating

Accounts

Typetotal exemption full
Due Date30/04/2026
Filing Date17/12/2024
Latest Accounts31/07/2024

Trading Addresses

Sandgate House, 102 Quayside, Newcastle Upon Tyne, NE13DXRegistered

Related Companies

5
eyetech innovations ltd
live
genedrive plc
live
medtechtomarket holdings limited
live
genedrive diagnostics ltd
live
qiagen manchester limited
live

Contact

Sandgate House 102 Quayside, Newcastle Upon Tyne, Tyne And Wear, NE13DX